Coronavirus
Pfizer May Seek Approval for Adult Covid Booster Shots as Soon as This Week
Pfizer and BioNTech are soon expected to submit for approval regarding booster shots of their COVID-19 vaccine for all adults.
The request to authorize boosters for anyone 18 and older could be submitted as early as this week and is expected to obtain the approval of the Food and Drug Administration (FDA), according to The Washington Post.
At present, booster shots from Moderna and Pfizer-BioNTech are available six months after a person’s second dose to groups who are 65 and older, are high-risk for COVID-19 because of medical conditions or have increased chances of exposure as a result of where they live or work. The Johnson & Johnson booster shot is available to anyone 18 and older two months after receiving the company’s single shot.
